5 articles
H.B. Fuller's board rejected Ancora Holdings' $1.1-1.2 billion offer for its building adhesives solutions (BAS) unit, citing undervaluation. The company plans to integrate its AMS acquisition while ma
Activist investor Ancora Holdings Group proposed acquiring H.B. Fuller's building adhesives segment for $1.1–1.2 billion in cash, escalating its campaign against the US adhesives producer.
H.B. Fuller proposed a £715 million acquisition of wound-care supplier AMS, facing criticism from activist investor Ancora Holdings who urged deleveraging. The deal aims to expand market reach and ach
Ancora Holdings renewed its proxy fight threat against HB Fuller over the £715 million acquisition of Advanced Medical Solutions (AMS). HB Fuller aims to expand into medical adhesives, though investor
Activist investor Ancora Holdings urges Ashland Inc., a specialty chemicals firm, to pursue a sale valued at $4.5 billion due to undervaluation. Potential buyers include Croda and Nouryon, while Ancor
ChemBrief